Citation Impact
Citing Papers
The Immunology of Fibrosis
2013
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Cancer statistics, 2018
2018 Standout
Hepatocellular carcinoma
2003 Standout
Hepatitis C virus kinetics during and immediately after liver transplantation
2002
Primary Biliary Cirrhosis
2005
Hepatitis C Virus–Specific CD4+T Cell Response after Liver Transplantation Occurs Early, Is Multispecific, Compartmentalizes to the Liver, and Does Not Correlate with Recurrent Disease
2001 StandoutNobel
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C
2001
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
2002
Hepatocellular carcinoma
2018 Standout
Autoimmune liver disease: overlap and outliers
2007
Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s Perspective
2002
Sjögren's syndrome
2005 Standout
Mechanisms of liver fibrosis
2005
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
2006 StandoutNature
Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
1993 Standout
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Nonalcoholic Fatty Liver Disease
2002 Standout
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
2017
Hepatocellular carcinoma
2012 Standout
Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection
1999
Analgesics in Patients with Hepatic Impairment
2012
Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation
1999
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome
2011
Hepatitis C Infection in Liver Transplantation
2001
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
2012
Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: A cohort analysis
1999
Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma
2009
Ursodeoxycholic Acid or Clofibrate in the Treatment of Non–Alcohol–Induced Steatohepatitis: A Pilot Study
1996
The X chromosome and immune associated genes
2011
Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation
1998
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis
2005
Mitochondrial control of cell death
2000 Standout
Portal hypertensive bleeding in cirrhosis
2016 Standout
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
The X chromosome in immune functions: when a chromosome makes the difference
2010
Are Patients with Child’s A Cirrhosis and Hepatocellular Carcinoma Appropriate Candidates for Liver Transplantation?
2011
Adaptive Immunity to the Hepatitis C Virus
2010
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Hydrophilic bile salt ursodeoxycholic acid protects myocardium against reperfusion injury in a PI3K/Akt dependent pathway
2005
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
2001 Standout
Personalized treatment of patients with very early hepatocellular carcinoma
2016
A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.
1998
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Effects of fibrates on serum lipids and atherosclerosis
1988
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Effect of preoperative endoscopic biliary drainage on infectious morbidity after pancreatoduodenectomy: a case-control study
2008
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection
2010
Ursodeoxycholic Acid Treatment of Refractory Chronic Graft-versus-Host Disease of the Liver
1992
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
1999 Standout
IgG4-related disease
2014 Standout
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
2004
Advances in Pediatric Nonalcoholic Fatty Liver Disease†
2009
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Sex differences in immune responses
2016 Standout
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
2006 Standout
Tauro-β-muricholate preserves choleresis and prevents taurocholate-induced cholestasis in colchicine-treated rat liver
1992
Cystic Fibrosis Transmembrane Conductance Regulator Mediates the Cyclic Adenosine Monophosphate–Induced Fluid Secretion But Not the Inhibition of Resorption in Mouse Gallbladder Epithelium
1997 StandoutNobel
Clinical states of cirrhosis and competing risks
2017
Hepatocellular Carcinoma
2011 Standout
Scintigraphic Documentation of An Improvement in Hepatobiliary Excretory Function After Treatment With Ursodeoxycholic Acid in Patients With Cystic Fibrosis and Associated Liver Disease
1992
Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinomas: A Meta-Analysis of Randomized and Nonrandomized Controlled Trials
2014
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus–Related Cirrhosis
2009
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.
1995
Complications of radiofrequency coagulation of liver tumours
2002
Hepatocellular Carcinoma
2019 Standout
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
2013
Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.
2013
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
2013
Primary Biliary Cirrhosis
2011 Standout
Elevated Plasma Cardiac Troponin T Levels Caused by Skeletal Muscle Damage in Pompe Disease
2016
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism
2005
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
2002
Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates
2012
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Hepatitis C and liver transplantation
2001
Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma
2011
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database
2017
Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients
1997 StandoutNobel
IFN-α amplifies human naïve B cell TLR-9-mediated activation and Ig production
2009
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of Massimo Zuin being referenced
Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial
1993
Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies
2002
Cardiovascular Risk Factors, Nonalcoholic Fatty Liver Disease, and Carotid Artery Intima-Media Thickness in an Adolescent Population in Southern Italy
2010
Effect of different doses of ursodeoxycholic acid in chronic liver disease
1989
Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis
1990
Late-Onset Autoimmunity: The Paradigm of Primary Biliary Cirrhosis – A Mini-Review
2008
Ten‐year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double‐blind, placebo‐controlled trial on symptomatic patients
2001
Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis
1997
Safety and efficacy of laparoscopic radiofrequency of hepatocellular carcinoma in patients with liver cirrhosis
2003
Acute liver and renal failure during treatment with buprenorphine at therapeutic dose
2008
Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis
2003
Long-term outcome of laparoscopic ablation therapies for unresectable hepatocellular carcinoma: a single European center experience of 426 patients
2015
Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis
2006
Radiofrequency interstitial thermal ablation of hepatocellular carcinoma in liver cirrhosis
2001
Surgical Resection Versus Laparoscopic Radiofrequency Ablation in Patients With Hepatocellular Carcinoma and Child-Pugh Class A Liver Cirrhosis
2009
Prophylaxis against HCV recurrence after liver transplantation: Effect of interferon and ribavirin combination
1997
Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis†
2007
Repeated bile acid therapy for the long-term management of cholesterol gallstones
1996
X Monosomy in Female Systemic Lupus Erythematosus
2007
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy
2014
Predicting Mortality Risk in Patients With Compensated HCV-Induced Cirrhosis: A Long-Term Prospective Study
2009
Interferon alpha and its contribution to autoimmunity.
2006
Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy
1998
Bile acid-induced inhibition of the lymphoproliferative response to phytohemagglutinin and pokeweed mitogen: An in vitro study
1980
X Chromosome Monosomy: A Common Mechanism for Autoimmune Diseases
2005
Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy.
1998
Ursodeoxycholic acid for chronic liver diseases.
1988
Parenteral Calcitonin for Metabolic Bone Disease Associated With Primary Biliary Cirrhosis
1994
Factors predicting early response to treatment with recombinant interferon alpha-2a in chronic non-A, non-B hepatitis. Preliminary report of a long-term trial.
1993
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis
2002
Effects of fenofibrate on biliary lipids and bile acid pool size in patients with type IV hyperlipoproteinemia
1985
Chenodeoxycholic Acid and Ursodeoxycholic Acid Effects in Endogenous Hypertriglyceridemias. A Controlled Double‐Blind Trial
1981
Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration
1991
Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status
1998